Leukemia

Welcome to Leukemia

Leading journal covering all aspects of the research and treatment of leukemia and allied diseases.

Current issue

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
Philipp A. Reuken
Andreas Stallmach
Michael Bauer

Correspondence Open Access 19 Feb 2021
Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study
Vincent H. J. van der Velden
Monika Brüggemann
Vincent H. J. van der Velden

Correspondence Open Access 19 Feb 2021
Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab
Shuntaro Ikegawa
Yusuke Meguri
Ken-ichi Matsuoka

Correspondence 17 Feb 2021
Two decades of targeted therapies in acute myeloid leukemia
David G. J. Cucchi
Tobias B. Polak
Jeroen J. W. M. Janssen

Review Article 15 Feb 2021
Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy
Stefania Trino
Daniela Lamorte
Ilaria Laurenzana

Review Article Open Access 09 Dec 2020
PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis
E. G. Garcia
A. Veloso
D. M. Langenau

Article 30 Jun 2020

Contents

View all issues

Featured

FOCUS COLLECTION: Caring for those with haematological disorders during the Covid-19 pandemic

During this extraordinary time Leukemia is committed to providing research which will help our readers care for people with haematological disorders at risk of SARS-CoV2-infection and COVID-19. This collection showcases the articles published thus far.

Announcement
Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)
Matthew Ho
Ashish Patel
Giada Bianchi

Review Article 12 Oct 2020
Hematopoietic stem and progenitor cell signaling in the niche
Stephanie N. Hurwitz
Seul K. Jung
Peter Kurre

Review Article 19 Oct 2020
Acknowledging the impact of Covid-19

As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.

Announcement

Leukemia is a Transformative Journal; authors can publish using the traditional publishing route OR Open Access.

Our Open Access option complies with funder and institutional requirements.

Browse articles

Targeted based therapy in nodal T-cell lymphomas
Dai Chihara
Milos Miljkovic
Francisco Vega

Review Article 04 Mar 2021
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
Bruno Fattizzo
Robin Ireland
Austin G. Kulasekararaj

Article Open Access 04 Mar 2021
Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome
Genki Yamato
Takao Deguchi
Hideki Muramatsu

Letter Open Access 03 Mar 2021
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms
Alexandre Guy
Johanne Poisson
Chloe James

Review Article 03 Mar 2021
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
Reid W. Merryman
Luca Castagna
Carmelo Carlo-Stella

Article 03 Mar 2021
Blood cancer driver Musashi-2 as therapeutic target in chronic lymphocytic leukemia
Lukas Kazianka
Philipp B. Staber

Comment 02 Mar 2021
Enhanced thrombin/PAR1 activity promotes G-CSF- and AMD3100-induced mobilization of hematopoietic stem and progenitor cells via NO upregulation
Neta Nevo
Lizeth-Alejandra Ordonez-Moreno
Orit Kollet

Letter 02 Mar 2021
Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival
Ghaith Abu-Zeinah
Spencer Krichevsky
Richard T. Silver

Article 02 Mar 2021
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML
Ilaria Gionfriddo
Lorenzo Brunetti
Brunangelo Falini

Article Open Access 02 Mar 2021

During this extraordinary time Leukemia is committed to providing research which will help our readers care for people with haematological disorders at risk of SARS-CoV2-infection and COVID-19. We encourage you to submit relevant research or correspondence, which whilst keeping our high standards of quality and accuracy, will be expedited through peer review and rapidly published online. Below is a selection of article already published – more to follow soon. All research featured in this collection will be free to access until the end of the pandemic.

Collection 11 Jan 2021

Welcome to Leukemia

Current issue

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection

Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study

Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab

Two decades of targeted therapies in acute myeloid leukemia

Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy

PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis

Featured

FOCUS COLLECTION: Caring for those with haematological disorders during the Covid-19 pandemic

Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)

Hematopoietic stem and progenitor cell signaling in the niche

Acknowledging the impact of Covid-19

Browse articles

Targeted based therapy in nodal T-cell lymphomas

Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia

Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Blood cancer driver Musashi-2 as therapeutic target in chronic lymphocytic leukemia

Enhanced thrombin/PAR1 activity promotes G-CSF- and AMD3100-induced mobilization of hematopoietic stem and progenitor cells via NO upregulation

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML

Collections

Caring for those with haematological disorders during the Covid-19 pandemic

Trending - Altmetric

Quick links

Discover content

Publishing policies

Author & Researcher services

Libraries & institutions

Advertising & partnerships

Career development

Regional websites

Legal & Privacy

Featured

Advertisement

Trending - Altmetric

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection

Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML

Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival

Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia

Search

Quick links